Gene · 57721
Papers4,298
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,881 to 1,900 of 4,298
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comprehensive analyses of N6 -methyladenosine-related long noncoding RNA profiles with prognosis, chemotherapy response, and immune landscape in small cell lung cancer. | Cancer Sci | 2022 | 36047973 | PubTator, text mining | PubMed |
| m6A Regulator-Based Exosomal Gene Methylation Modification Patterns Identify Distinct Microenvironment Characterization and Predict Immunotherapeutic Responses in Colon Cancer. | Oxid Med Cell Longev | 2022 | 36046691 | PubTator, text mining | PubMed |
| Enhancer RNAs step forward: new insights into enhancer function. | Development | 2022 | 36039999 | PubTator, text mining | PubMed |
| m6A regulation of cortical and retinal neurogenesis is mediated by the redundant m6A readers YTHDFs. | iScience | 2022 | 36039295 | PubTator, text mining | PubMed |
| The role of lncRNAs and XIST in oral cancer. | Front Cell Dev Biol | 2022 | 36035993 | PubTator, text mining | PubMed |
| LncRNAs divide and rule: The master regulators of phase separation. | Front Genet | 2022 | 36035193 | PubTator, text mining | PubMed |
| The emerging roles and mechanism of m6a in breast cancer progression. | Front Genet | 2022 | 36035182 | PubTator, text mining | PubMed |
| SETD2 regulates gene transcription patterns and is associated with radiosensitivity in lung adenocarcinoma. | Front Genet | 2022 | 36035179 | PubTator, text mining | PubMed |
| Comprehensive analysis of molecular features, prognostic values, and immune landscape association of m6A-regulated immune-related lncRNAs in smoking-associated lung squamous cell carcinoma. | Front Genet | 2022 | 36035178 | PubTator, text mining | PubMed |
| m6A regulator-based methylation modification patterns and characterization of tumor microenvironment in acute myeloid leukemia. | Front Genet | 2022 | 36035161 | PubTator, text mining | PubMed |
| Comprehensive analysis of the m6A-related molecular patterns and diagnostic biomarkers in osteoporosis. | Front Endocrinol (Lausanne) | 2022 | 36034449 | PubTator, text mining | PubMed |
| Novel insight into m6A regulator-mediated methylation modification patterns and immune characteristics in intracranial aneurysm. | Front Aging Neurosci | 2022 | 36034129 | PubTator, text mining | PubMed |
| Identification and Validation of an m6A-Related LncRNA Signature to Predict Progression-Free Survival in Colorectal Cancer. | Pathol Oncol Res | 2022 | 36032659 | PubTator, text mining | PubMed |
| The Impact of Epitranscriptomics on Antiviral Innate Immunity. | Viruses | 2022 | 36016289 | PubTator, text mining | PubMed |
| Dynamic Alteration Profile and New Role of RNA m6A Methylation in Replicative and H2O2-Induced Premature Senescence of Human Embryonic Lung Fibroblasts. | Int J Mol Sci | 2022 | 36012545 | PubTator, text mining | PubMed |
| Post-Transcriptional Modifications of RNA as Regulators of Apoptosis in Glioblastoma. | Int J Mol Sci | 2022 | 36012529 | PubTator, text mining | PubMed |
| Multiple Roles of m6A RNA Modification in Translational Regulation in Cancer. | Int J Mol Sci | 2022 | 36012237 | PubTator, text mining | PubMed |
| Epigenetic Alterations in Sports-Related Injuries. | Genes (Basel) | 2022 | 36011382 | PubTator, text mining | PubMed |
| The m6A-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Tumor Immune Infiltration in Ovarian Cancer. | Cancers (Basel) | 2022 | 36011053 | PubTator, text mining | PubMed |
| m6A Methylation Regulators Are Predictive Biomarkers for Tumour Metastasis in Prostate Cancer. | Cancers (Basel) | 2022 | 36011028 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57721/papers?page=95